Home › RPT-INTERVIEW-Halozyme CEO sees blockbuster potential in its cancer drug
 

Keywords :   


RPT-INTERVIEW-Halozyme CEO sees blockbuster potential in its cancer drug

2015-01-08 16:16:25| Biotech - Topix.net

The drug, PEGPH20, being tested against pancreatic cancer, has the potential to help treat several other types of solid tumor cancers, its chief executive said in an interview. Halozyme discussed interim data from a Phase II study of PEGPH20 with analysts and investors in New York on Wednesday, demonstrating its likelihood of delaying a worsening of the deadly cancer.

Tags: potential drug cancer ceo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
15.05Tom Hardy Is Jo Malone Londons New Ambassador for Cypress & Grapevine Cologne Intense
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Eastern North Pacific Tropical Weather Outlook
15.05European Wax Center\'s EWC Treat Brightening Ingrown Hair Wipes Awarded
15.05EchoStar pay TV subscribers down 348,000 in 1Q 2024
15.05Atlantic Tropical Weather Outlook
15.05PBE Makes Investment in Plus-Size Adult Incontinence Products
More »